New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
CAMP4 Therapeutics Corporation (CAMP) vs Ocugen, Inc. (OCGN)
- CAMP4 Therapeutics Corporation CAMP 3.79 −5.25%
- Ocugen, Inc. OCGN 0.77 +5.48%
CAMP4 Therapeutics Corporation and Ocugen, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Ocugen, Inc. are of similar size ($251.0M and $248.6M). CAMP4 Therapeutics Corporation grew revenue faster over the last twelve months: 52.0% against −11.0%. Ocugen, Inc. has the higher net margin (−1,367.6% vs −2,276.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Ocugen, Inc. leads on 7 and CAMP4 Therapeutics Corporation on 6.
Valuation
Profitability
| Metric | CAMP | OCGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (1,001.05%) | (1,444.47%) | 0.00% |
| Net margin | (2,276.33%) | (1,367.61%) | 0.00% |
| Free cash flow margin | — | (1,337.16%) | 0.00% |
| Return on equity | (146.12%) | 923.92% | (51.58%) |
| Return on assets | (109.89%) | (78.91%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack